These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8612340)

  • 1. Mass spectrometry in Parkinson's disease.
    Niwa T
    Clin Chim Acta; 1995; 241-242():223-50. PubMed ID: 8612340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurotoxin candidates as pathogenic agents of Parkinson's disease].
    Naoi M
    No To Shinkei; 1997 Sep; 49(9):793-803. PubMed ID: 9310995
    [No Abstract]   [Full Text] [Related]  

  • 3. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
    Biochem Biophys Res Commun; 1991 Jun; 177(2):603-9. PubMed ID: 2049084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
    Kajita M; Niwa T; Fujisaki M; Ueki M; Niimura K; Sato M; Egami K; Naoi M; Yoshida M; Nagatsu T
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):345-51. PubMed ID: 7581910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
    Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
    Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
    J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous synthesis of N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of N-methylisoquinolinium ion, in the brains of primates with parkinsonism after systemic administration of 1,2,3,4-tetrahydroisoquinoline.
    Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Yoshida M; Kawachi M; Naoi M; Nagatsu T
    J Chromatogr; 1990 Nov; 533():145-51. PubMed ID: 2127934
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of N-methyldopamine in parkinsonian and normal human brains.
    Kajita M; Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Watanabe K; Nagatsu T
    J Chromatogr; 1993 Mar; 613(1):1-8. PubMed ID: 8458887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
    Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
    FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain aging and Parkinson's disease].
    Nagatsu T
    Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):115-22. PubMed ID: 2200908
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
    Naoi M; Maruyama W; Niwa T; Nagatsu T
    J Neural Transm Suppl; 1994; 41():197-205. PubMed ID: 7931227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
    Makino Y; Ohta S; Tachikawa O; Hirobe M
    Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent research advances in Parkinson's disease: Part I.
    Friedman J
    R I Med J (1976); 1986 Jul; 69(7):319-22. PubMed ID: 3489271
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in parkinsonian brain.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
    Adv Neurol; 1993; 60():234-7. PubMed ID: 8420140
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry.
    Niwa T; Takeda N; Sasaoka T; Kaneda N; Hashizume Y; Yoshizumi H; Tatematsu A; Nagatsu T
    J Chromatogr; 1989 Jul; 491(2):397-403. PubMed ID: 2808624
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease.
    Soto-Otero R; Riguera-Vega R; Méndez-Alvarez E; Sánchez-Sellero I; López-Rivadulla Lamas M
    Biochem Biophys Res Commun; 1996 May; 222(2):607-11. PubMed ID: 8670252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The search for endogenous or exogenous MPTP-like substances].
    Nagatsu T
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1497-500. PubMed ID: 2517047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.